BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 10063578)

  • 1. The management concept of breast cancer with clinically node-negative/imaging node-positive disease.
    Bi Z; Ren TY; Zhang ZP; Wang YS
    Int J Surg; 2023 Nov; 109(11):3727-3729. PubMed ID: 37678269
    [No Abstract]   [Full Text] [Related]  

  • 2. Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: comment.
    Kleebayoon A; Wiwanitkit V
    Radiol Med; 2023 Dec; 128(12):1593-1594. PubMed ID: 37962776
    [No Abstract]   [Full Text] [Related]  

  • 3. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sentinel lymphadenectomy: an alternative to axillary lymphadenectomy in breast carcinoma].
    Berclaz G; Crazzolara AO; Altermatt HJ; Aebi S; Fey MF; Hänggi W; Dreher E
    Schweiz Med Wochenschr; 1998 Oct; 128(44):1730-6. PubMed ID: 9846346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
    Crossin JA; Johnson AC; Stewart PB; Turner WW
    Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study.
    Rehman S; Sardi A; Spiegler E; Colandrea J; Frishberg D
    Md Med J; 1999; 48(3):105-10. PubMed ID: 10394225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic mapping for the dissection of the sentinel node in the treatment of breast carcinoma.
    Carcoforo P; Feggi L; Sartori A; Navarra G; Pozza E; Donini I
    J Exp Clin Cancer Res; 1999 Mar; 18(1):75-7. PubMed ID: 10374682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sentinel lymph nodes in breast carcinoma].
    Büchels HK; Vogt H; Wagner T; Fleischer J
    Zentralbl Chir; 1998; 123 Suppl 5():70-1. PubMed ID: 10063578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sentinel node--malignant melanoma and primary breast cancer. The significance of sentinel node in the treatment of malignant melanoma and primary breast cancer].
    Axelsson CK; Løntoft E; Bak M
    Ugeskr Laeger; 1999 Apr; 161(16):2343-7. PubMed ID: 10235037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective sentinel lymphadenectomy for breast cancer.
    Cox CE; Weinberg ES; Furman B; White LB; Patel J; Dickson DC; King J
    Cancer Treat Res; 2005; 127():77-104. PubMed ID: 16209078
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.